Markus Winterberg LTS Lohmann Therapie Systeme
Markus Winterberg LTS Lohmann Therapie Systeme Head of Analytical Development, Microbiology, and Quality Control
Markus is Head of Analytical Development, Microbiology, and Quality Control for the MAP-Program at LTS Lohmann Therapie Systeme AG in Andernach. He studied biology at Philipps University in Marburg, Germany, and was awarded a PhD in Parasitology in 2009 for his work on the membrane physiology and biochemistry of the Malaria parasite. From 2009 to 2015 he expanded his track record in infectious disease research at The Australian National University in Canberra, Australia. In 2015, he accepted a position for the University of Oxford, leading the Clinical Pharmacology laboratories at the Mahidol-Oxford Tropical Medicine Research Unit in Bangkok, Thailand. Markus has extensive experience in bio-analytics and infectious disease research with more than 30 peer-reviewed publications and more than $3.5M of competitive research funding over the past years. He participated in more than 30 clinical trials (phase 1 - 4), bioavailability and bioequivalence studies. In 2019 he joined LTS as Head of Analytical Development for the MAP Program. He has been heading the Microbiology and Quality Control for the MAP Program since 2021.